Lonza Group AG against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-10-13T15:30:39+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month LONN.SW is +6.6% and MRNA +50.2%; over year to date LONN.SW is +5.3% and MRNA +633.3%.
| LONN.SW | MRNA | |
|---|---|---|
| Price | $566.40 | $216.25 |
| 1 day | -1.3% | +1.2%lead |
| 5 days | -1.7% | +15.4%lead |
| 1 month | +6.6% | +50.2%lead |
| 6 months | +9.6% | +326.7%lead |
| Year to date | +5.3% | +633.3%lead |
| 52-week position | 78% of range | 95% of range |
| 52-week range | $454.60–$597.80 | $22.28–$227.46 |
| vs 50-day average | below $567.65 | above $144.66 |
| vs 200-day average | above $532.75 | above $74.46 |
| RSI (14) | 52 | 64 |
| Next earnings | 2026-01-28 | 2026-11-06 |
LONN.SW trades at $566.40, below its 50-day average of $567.65, and above the 200-day at $532.75. It sits at 78% of its 52-week range ($454.60–$597.80); 14-day RSI is 52, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $567.65 (0.2% away) and the first support below is $554.60 (2.1% down). On the checklist the page runs for every asset, 3 of 6 checks read bullish — the lean is bullish.
MRNA trades at $216.25, above its 50-day average of $144.66, and above the 200-day at $74.46. It sits at 95% of its 52-week range ($22.28–$227.46); 14-day RSI is 64, in neutral territory; an average session moves it about 7.4%. For levels, the first level overhead is $225.00 (4.0% away) and the first support below is $200.00 (7.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 7.4% against 2.3% for LONN.SW, so an identical position size carries roughly 3.2× the daily risk.
The comparison turns on those levels: LONN.SW clearing $567.65 or losing $554.60; MRNA clearing $225.00 or losing $200.00. Until one of them gives way, the relative reading above stands.